An International, Multicentre, Open Label Study To Assess The Effectiveness Of Amlodipine -Atorvastatin Combination In Subjects With Hypertension and Dyslipidaemia. (The JEWEL Study)

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.126 个研究点分布在 1 个国家目标入组 1,250 人开始时间: 2004年10月1日最近更新: 2021年1月27日

适应症

试验速览

阶段: 3 期
状态: 已完成
发起方
入组人数: 1,250
试验地点: 126
主要终点: LDL-C targets as defined by their governing guidelines.

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

To evaluate the effectiveness of amlodipine/atorvastatin therapy by assessing the percentage of subjects who reach target blood pressure (BP) and LDL-C targets as defined by their governing guidelines.

研究设计

研究类型: Interventional
分配方式: Non Randomized
干预模型: Single Group
主要目的: Treatment
盲法: None

入排标准

年龄范围: 18 Years 至 80 Years（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•Patients who are above target LDL-C and BP who are eligible for treatment

排除标准

•High liver enzymes

结局指标

主要结局

LDL-C targets as defined by their governing guidelines.

To evaluate the number of patients who reach target blood pressure (BP) and

次要结局

parameters: LDL-C, total cholesterol (TC), triglycerides, high-density lipoprotein
To assess changes from baseline to end of treatment for the following efficacy
(SBP) and Diastolic Blood Pressue (DBP).
cholesterol (HDL-C), HDL-C/LDL-C ratio, TC/HDL-C ratio. Systolic Blood Pressure

研究者

发起方

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

申办方类型

Industry

研究点 (126)

Loading locations...

相似试验

已完成

4 期

Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia.HypertensionHyperlipidemia

NCT00174304Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1,120

已完成

4 期

Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And DyslipidemiaHypertensionHyperlipidemia

NCT00174330Pfizer's Upjohn has merged with Mylan to form Viatris Inc.330

已完成

3 期

TElmisartan and AMlodipine Single Pill sTudy With Patients Not on Goal With Mono rAas Therapy-switchHypertension

NCT01134393Boehringer Ingelheim502

已完成

不适用

The study for the efficacy of amlodipine/atorvastatin combination drug in patients with type 2 diabetes complicated with hypertention and hypercholestrolemia.Type 2 diabetes complicated with hypertention and hypercholestrolemia

JPRN-UMIN000010895Kanazawa Medical University Diabetes and Endocrinology240

已完成

3 期

Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II HypertensionHypertension

NCT00527514Daiichi Sankyo185